AI technology can be used to detect potentially fatal clots before they attack.
It says that, according to scientists at the University of Tokyo, they created a non-invasive method for observing coagulation activity in the blood when it occurs.
new artificial intelligence The tool uses powerful microscopes to monitor platelets in real time, researchers shared in a press release from the university.
What is Artificial Intelligence (AI)?
Platelets are small blood cells that help to form blood clots to stop bleeding and play a “important role” especially in heart disease. Coronary Artery Diseaseaccording to Dr. Kazutoshi Heroes, the lead author of the study.
Too high platelet counts can increase the risk of clots.
Scientists at the University of Tokyo have discovered a non-invasive method for observing coagulation activity in the blood. (istock)
Patients with coronary artery disease are usually treated to prevent dangerous blood clots Antiplatelet drugs.
“However, it remains difficult to accurately assess how well these drugs work in each individual, and this makes monitoring platelet activity an important goal for both physicians and researchers,” Hirose said in a press release.
How the tool works
Traditional methods for monitoring platelet activity often rely on indirect measurements or invasive procedures.
With AI tools, high-power microscopes act like “ultra-fast cameras that take sharp photos of flow blood cells.”
Artificial intelligence transforms patient care and reduces burnout, doctors say
“Like traffic cameras capture every car on the road, our microscope captures thousands of images Blood cells “Then we use artificial intelligence to analyze those images,” he said.
AI can distinguish between single platelets (“one car”), chunks of platelets (“like a traffic jam”), or white blood cells tagged along (“like a police car caught in a jam”).
“Now, doctors often give them blood thinning medication and want them to be at work. This way we were able to see if the treatment was actually working.”
“The technique stands out because doctors can directly observe platelets in the bloodstream and measure how they interact and form masses in real time,” says Godaisaku, a professor in the Department of Chemistry at the University of Tokyo, in this release.
“Our research has shown to be extremely effective for patients Coronary Artery Diseaseit is one of the most common causes of heart attacks and one of the leading causes of death in the US and around the world,” he added.
Researchers say traditional methods of monitoring platelet activity often rely on indirect measurements or invasive procedures. (istock)
When researchers tested the technology of more than 200 patients, they discovered that people with more severe heart problems had more clumps in their blood.
Blood sample They noted that the results were taken from the patient’s arms and tested with the tool, resulting in roughly the same results as blood taken directly from the arteries of the heart.
Impact on treatment
Harvey Castro, a Texas-based emergency physician and AI expert, described the impact as important for patient care.
“Today, we rely on indirect lab markers or invasive Caslab blood draws, but we determine the risk of clotting,” Castro, who was not involved in the study, told Fox News Digital.
Click here to get the Fox News app
“This technology Turn normal venous drawing into living telemetry with platelet behavior, giving the answer in seconds rather than hours. ”
Researchers say these advancements could change the standard of care for coronary heart disease patients.
Click here to sign up for our health newsletter
“Usually, if a doctor wants to understand what’s going on in the arteries, especially the coronary arteries, you’ll need to do invasive procedures, such as inserting a catheter into the wrist or gro diameter to collect blood,” Hirose said.
In a study of the effectiveness of the tool, regular blood tests from the arm showed roughly the same results as blood taken directly from the arteries of the heart. (istock)
“What we found was that simply taking a normal blood sample from the vein in our arm can provide meaningful information about platelet activity within the artery.”
Visit us for more health articles www.foxnews.com/health
Goda agreed that this tool could be safer Personalized treatment For heart disease patients.
“Now, doctors often give them blood thinning medication and hope they’re at work,” he said. “Using this method, we were able to see if the treatment was actually working in each patient.”
Potential limitations
Castro warned of that technology Not yet ready for wide use.
“The microscope is a state-of-the-art research device and is not a bedside device yet,” he told Fox News Digital. “All ERs need to miniaturize and lower costs before they can be used.”
“What we found was that simply taking a normal blood sample from the vein in our arm can provide meaningful information about platelet activity within the artery.” (istock)
Looking ahead, after further research, Castro envisions that this innovation could change patient point-of-care decisions.
“Five years from now, I can imagine a point-of-care analyzer that can adjust antiplatelet medications and how to quickly and safely titrate oxygen in the patient in front of me,” he said.
